ATXG

ADDENTAX GROUP CORP.

Nasdaq · Services-Mailing, Reproduction, Commercial Art & Photography · Inc. NV · CIK 0001650101
$4.71 -5.80% $3.7M
Vol
Market Cap$3.7M
Cap SizeNano Cap
Inst. Holders2 funds
Inst. Value$28.3K
Inst. Activity1 buys / 0 sells
SEC Reports2
Exchange Nasdaq·Sector Services-Mailing, Reproduction, Commercial Art & Photography·Inc. NV·CIK 0001650101·Prev Close $5.00

Top Institutional Holders

FundValueMove
TWO SIGMA INVESTMENTS, LP$21.6KADD
RENAISSANCE TECHNOLOGIES LLC$6.7K

Recent Insider Trades

DateInsiderTypeValue
May 15, 2026Wu RuiJ$167.5K
Apr 8, 2026Wu RuiA$0.00
2 institutional holders with $28.3K total value (72,106 shares) as of 2025-Q4. Top holders: TWO, RENAISSANCE. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1TWO SIGMA INVESTMENTS, LP55,006$21.6K76.3%ADD +88.3%
2RENAISSANCE TECHNOLOGIES LLC17,100$6.7K23.7%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
TWO SIGMA INVESTMENTS, LPADD29,20655,006+88.3%$21.6K2025-Q4
TWO SIGMA INVESTMENTS, LPNEW29,206$29.2K2025-Q3
1 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 15, 2026Wu RuiChief Operating OfficerJ33,500$5.00$167.5K
Apr 8, 2026Wu RuiChief Operating OfficerA66,667$0.00$0.00

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.